Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
On January 12, 2024, the Board of Directors (the “Board”) of Teradyne, Inc. (“Teradyne”) elected Bridget A. van Kralingen as a director of Teradyne and appointed her to the Board’s Compensation Committee and Nominating and Corporate Governance Committee.
The Board has determined that Ms. van Kralingen is independent. To be considered independent by the Board, a director must satisfy the definitions pursuant to the Securities Exchange Commission and Nasdaq rules and, in the Board’s judgment, not have a material relationship with Teradyne. Teradyne’s Corporate Governance Guidelines, which include director qualification standards, are available on Teradyne’s web site at www.teradyne.com under the “Governance” section of the “Investor Relations” link.
Ms. van Kralingen will receive compensation at the rate of $90,000 per year.
On January 12, 2024, Ms. van Kralingen received a grant of restricted stock units pursuant to Teradyne’s 2006 Equity and Cash Compensation Incentive Plan in an amount of shares having a fair market value equal to $74,290 based on the Board’s annual equity compensation of $230,000 prorated daily to reflect the period from her date of appointment to the expected date of the 2024 Annual Meeting of Shareholders. This grant vests in full on the earlier of the date the 2024 Annual Meeting of Shareholders is held or the last Thursday in May 2024.
There are no arrangements or understandings between Ms. van Kralingen and any other persons pursuant to which she was selected to serve as a director of Teradyne. In addition, there are no transactions between Teradyne and Ms. van Kralingen or her immediate family members requiring disclosure under Item 404(a) of Regulation S-K promulgated under the Exchange Act.
On January 12, 2024, Teradyne issued a press release announcing the election of Ms. van Kralingen to the Board effective as of January 12, 2024. A copy of the press release is attached hereto as Exhibit 99.1.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits